KSE Meezan Index Fund

Reading KSE Meezan Index Fund's prices and fees

KSE Meezan Index Fund is reported by MUFAP under Shariah Compliant Index Tracker, managed by Al Meezan Investment Management Limited. The pricing observation is dated 9 Oct 2026. NAV describes the reported net asset value per unit; it is not necessarily the amount an investor pays to enter or receives on redemption.

The reported offer value of PKR 176.4205 and repurchase value of PKR 172.0337 differ by PKR 4.3868 per unit on that date. This is offer minus repurchase, not a promised trading spread or an investor-specific charge. Confirm the applicable cutoff time, pricing convention and settlement terms with the provider. Do not automatically add the displayed load percentages to this difference; the quoted prices may already reflect some charges.

The reported year-to-date total expense ratio is 1.26%, dated 9 Oct 2026. TER is a fund expense measure, not a separate annual invoice calculated by this page. Management fees can be a component of expenses, so adding TER and management fee can double-count costs. Taxes, distribution treatment and any investor-specific concessions are outside these figures.

Category evidence and limitations

The comparison below uses only Shariah Compliant Index Tracker observations with the same stated return basis and performance validity date. Sample counts can differ by horizon. A missing figure is excluded from its sample, and no value is reconstructed.

Risks before using these figures

Equity holdings can lose value sharply. Company concentration, market liquidity and the timing of withdrawals matter; a historical return cannot establish a future recovery date.

Public eligibility does not confirm that a particular investor meets every provider requirement. The classification follows the official directory. Check the provider’s current Shariah disclosures for the actual scheme; this page is not a religious ruling. Payouts can reduce NAV without representing an equivalent total-return loss. The NAV chart therefore stays separate from MUFAP-reported performance.